269 related articles for article (PubMed ID: 21048198)
21. Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease.
Boxer AL; Garbutt S; Seeley WW; Jafari A; Heuer HW; Mirsky J; Hellmuth J; Trojanowski JQ; Huang E; DeArmond S; Neuhaus J; Miller BL
Arch Neurol; 2012 Apr; 69(4):509-17. PubMed ID: 22491196
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
[TBL] [Abstract][Full Text] [Related]
24. Can MRI screen for CSF biomarkers in neurodegenerative disease?
McMillan CT; Avants B; Irwin DJ; Toledo JB; Wolk DA; Van Deerlin VM; Shaw LM; Trojanoswki JQ; Grossman M
Neurology; 2013 Jan; 80(2):132-8. PubMed ID: 23269595
[TBL] [Abstract][Full Text] [Related]
25. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
[TBL] [Abstract][Full Text] [Related]
26. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
27. Prediction of pathology in primary progressive language and speech disorders.
Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
[TBL] [Abstract][Full Text] [Related]
28. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Illán-Gala I; Lleo A; Karydas A; Staffaroni AM; Zetterberg H; Sivasankaran R; Grinberg LT; Spina S; Kramer JH; Ramos EM; Coppola G; La Joie R; Rabinovici GD; Perry DC; Gorno-Tempini ML; Seeley WW; Miller BL; Rosen HJ; Blennow K; Boxer AL; Rojas JC
Neurology; 2021 Feb; 96(5):e671-e683. PubMed ID: 33199433
[TBL] [Abstract][Full Text] [Related]
29. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
[TBL] [Abstract][Full Text] [Related]
30. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
[TBL] [Abstract][Full Text] [Related]
31. Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP.
Olm CA; Burke SE; Peterson C; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M; Gee JC
Neuroimage Clin; 2023; 37():103285. PubMed ID: 36508888
[TBL] [Abstract][Full Text] [Related]
32. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.
Ohm DT; Peterson C; Lobrovich R; Cousins KAQ; Gibbons GS; McMillan CT; Wolk DA; Van Deerlin V; Elman L; Spindler M; Deik A; Siderowf A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol; 2020 Nov; 140(5):675-693. PubMed ID: 32804255
[TBL] [Abstract][Full Text] [Related]
33. Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes.
Tomé SO; Vandenberghe R; Ospitalieri S; Van Schoor E; Tousseyn T; Otto M; von Arnim CAF; Thal DR
Acta Neuropathol Commun; 2020 Apr; 8(1):61. PubMed ID: 32349792
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.
Rivero-Santana A; Ferreira D; Perestelo-Pérez L; Westman E; Wahlund LO; Sarría A; Serrano-Aguilar P
J Alzheimers Dis; 2017; 55(2):625-644. PubMed ID: 27716663
[TBL] [Abstract][Full Text] [Related]
36. Plasma proteome profiling identifies changes associated to AD but not to FTD.
Mofrad RB; Del Campo M; Peeters CFW; Meeter LHH; Seelaar H; Koel-Simmelink M; Ramakers IHGB; Middelkoop HAM; De Deyn PP; Claassen JAHR; van Swieten JC; Bridel C; Hoozemans JJM; Scheltens P; van der Flier WM; Pijnenburg YAL; Teunissen CE
Acta Neuropathol Commun; 2022 Oct; 10(1):148. PubMed ID: 36273219
[TBL] [Abstract][Full Text] [Related]
37. Frontotemporal lobar degeneration: diversity of FTLD lesions.
Seilhean D; Bielle F; Plu I; Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
[TBL] [Abstract][Full Text] [Related]
39. Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration.
Seo SW; Thibodeau MP; Perry DC; Hua A; Sidhu M; Sible I; Vargas JNS; Gaus SE; Rabinovici GD; Rankin KD; Boxer AL; Kramer JH; Rosen HJ; Gorno-Tempini ML; Grinberg LT; Huang EJ; DeArmond SJ; Trojanowski JQ; Miller BL; Seeley WW
Neurology; 2018 Mar; 90(12):e1047-e1056. PubMed ID: 29453245
[TBL] [Abstract][Full Text] [Related]
40. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
